Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas

Cancer Research

Volumn 58, Issue 14, 1998, Pages 3101-3104

  Grady, William M ^a   Rajput, Ashwani ^a   Myeroff, Lois ^a   Liu, Dong F ^a   Kwon, KiHo ^b   Willis, Joseph ^a   Markowitz, Sanford ^a,c,d  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d Ireland Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ARTICLE; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CARCINOGENESIS; COLON POLYP; CONTROLLED STUDY; DYSPLASIA; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 0032527902     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wang, C. Y., Eshleman, J., Willson, J., and Markowitz, S. TGF-β and substrate release are both inducers of apoptosis in a human colon adenoma cell line. Cancer Res., 55: 5101-5105, 1995.
2. Markowitz, S., Myeroff, L., Cooper, M., Traicoff, J., Kochera, M., Lutterbaugh, J., Swiriduk, M., and Willson, J. A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-β independence without inactivating the p53 tumor suppressor gene. J. Clin. Invest., 93: 1005-1013, 1994.
3. Hoosein, N., McKnight, M., Levine, A., Mulder, K., Childress, K., Brattain, D., and Brattain, M. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-β1. Exp. Cell Res., 181: 442-453, 1989.
4. Manning, A., Williams, A., Game, S., and Paraskeva, C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β(TGF-β): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene, 6: 1471-1476, 1991.
5. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R., Zborowska, E., Kinzler, K., Vogelstein, B., Brattain, M., and Willson, J. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
6. Parsons, R., Myeroff, L., Liu, B., Willson, J., Markowitz, S., Kinzler, K., and Vogelstein, B. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res., 55: 5548-5550, 1995.
7. Macias-Silva, M., Abdollah, S., Hoodless, P., Pirone, R., Attisano, L., and Wrana, J. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell, 87: 1215-1224, 1996.
8. Riggins, G., Kinzler, K., Vogelstein, B., and Thiagalingam, S. Frequency of smad gene mutations in human cancers. Cancer Res., 57: 2578-2580, 1997.
9. Riggins, G., Thiagalingam, S., Rozenblum, E., Weinstein, C., Kern, S., Hamilton, S., Willson, J., Markowitz, S., Kinzler, K., and Vogelstein, B. Mad-related genes in the human. Nat. Genet., 13: 347-349, 1996.
10. Liu, B., Nicolaides, N., Markowitz, S., Willson, J., Parsons, R., Jen, J., de la Chapelle, A., Hamilton, S., Kinzler, K., and Vogelstein, B. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat. Genet., 9: 48-53, 1995.
11. Thibodeau, S., Bren, G., and Schaid, D. Microsatellite instability in cancer of the proximal colon. Science (Washington DC), 260: 816-819, 1993.
12. Thibodeau, S., French, A., Roche, P., Cunningham, J., Tester, D., Lindor, N., Moslein, G., Baker, S., Liskay, M., Burgart, L., Honchel, R., and Halling, K. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res., 56: 4836-4840, 1996.
13. Kane, M., Loda, M., Gaida, G., Lipman, J., Mishra, R., Goldman, H., Jessup, J., and Kolodner, R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res., 57: 808-811, 1997.
14. Wang, J., Sun, L., Myeroff, L., Wang, X., Gentry, L., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J., and Brattain, M. Demonstration that mutation of the type II transforming growth factor βreceptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270: 22044-22049, 1995.
15. Hoang, J-M., Cottu, P. H., Thuille, B., Salmon, R. J., Thomas, G., and Hamelin, R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res., 57: 300-303, 1997.
16. Ionov, Y., Peinado, A., Malkhosyan, S., Shibata, D., and Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonie carcinogenesis. Nature (Lond.), 363: 558-561, 1993.
17. Myeroff, L., Parsons, R., Kim, S-J., Hedrick, L., Cho, K., Orth, K., Mathis, M., Kinzler, K., Lutterbaugh, J., Park, K., Bang, Y-J., Lee, H., Park, J-G., Lynch, H., Roberts, A., Vogelstein, B., and Markowitz, S. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55: 5545-5547, 1995.
18. Jacoby, R., Marshall, D., Kailas, S., Schlack, S., Harms, B., and Love, R. Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer. Gastroenterology, 109: 73-82, 1995.